Metaarth Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-07-2024
- Paid Up Capital ₹ 0.30 M
as on 04-07-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 35.15 Cr
as on 04-07-2024
- Revenue %
(FY 2022)
- Profit 2330.50%
(FY 2022)
- Ebitda 98.70%
(FY 2022)
- Net Worth 54.42%
(FY 2022)
- Total Assets 60.75%
(FY 2022)
About Metaarth Lifesciences
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company has closed loans amounting to ₹35.15 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Purnima Shukla and Ambrish Tiwari serve as directors at the Company.
- CIN/LLPIN
U21022HP2003PTC026023
- Company No.
026023
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Metaarth Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purnima Shukla  | Additional Director | 13-Jul-2023 | Current |
| Ambrish Tiwari | Additional Director | 13-Jul-2023 | Current |
Financial Performance of Metaarth Lifesciences.
Metaarth Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 2330.5% increase in profit. The company's net worth Soared by an impressive increase of 54.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Metaarth Lifesciences?
In 2019, Metaarth Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dfms Pharmaceuticals LimitedActive 6 years 1 monthPurnima Shukla and Ambrish Tiwari are mutual person
- Metaarth Investments Private LimitedActive 1 year 9 days
Purnima Shukla and Ambrish Tiwari are mutual person
- Metaarth Finserve Private LimitedActive 2 years 3 months
Purnima Shukla and Ambrish Tiwari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Small Industries Development Bank Of India Creation Date: 28 Mar 2012 | ₹4.00 Cr | Satisfied |
Small Industries Development Bank Of India Creation Date: 22 Dec 2010 | ₹5.40 Cr | Satisfied |
Small Industries Development Bank Of India Creation Date: 26 Jul 2010 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Metaarth Lifesciences?
Unlock and access historical data on people associated with Metaarth Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Metaarth Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metaarth Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
